Colorimetric Detection of Arsenic (III) and Mercury (II) Ions in Human Serum Albumin Samples Using Cysteine-Capped Gold Nanoparticles

Read full text
Authors: Sayo O. Fakayode, David K. Bwambok, Eris Arth, Ufuoma Benjamin, Rebecca Huisman, Allison Lugue, Alex Tokos, Kayley Owens, Peter Rosado Flores
Cited by: 1
References: 67

Abstract

A continued interest in developing a low-cost, rapid screening method for quantifying Hg (II) and As (III) in biological samples stems from the toxic effects of human exposure to these heavy metal ions. This study reports the use of cysteine-capped gold nanoparticles (CysAuNPs) for chemical sensing, colorimetric detection, and quantification of As (III) and Hg (II) ions in human serum albumin (HSA) under physiological conditions. Zeta potential measurements indicated that the CysAuNPs have a negative surface charge, which was decreased in the presence of HSA and reversed to a positive value upon binding of As (III) and Hg (II) metal ions. Circular dichroism (CD) spectroscopy revealed changes in HSA conformation upon binding to As (III) and Hg (II) ions. X-ray fluorescence enables rapid qualitative screening for As (III) and Hg (II) ions before colorimetric quantification. The figures of merit (R2 ≥ 0.940) and the low detection limits (0.05 ppm for As (III) ions and 0.02 ppm for Hg (II)) in serum albumin demonstrate the high sensitivity of the method. The developed calibration curves correctly quantified the concentration of As (III) and Hg (II) ions of independently prepared test validation samples in HSA with an accuracy of ≥95% over a period of seven months without recalibrations, demonstrating the stability of CysAuNPs in solution and the robustness of the method for analysis of As (III) and Hg (II) ions in serum albumin.

Fields of Study & Subjects

Protein Interaction Studies and Fluorescence Analysis Molecular Sensors and Ion Detection Arsenic contamination and mitigation

Publication details

Journal / source
Sensors
Publisher
MDPI AG
Volume
26
Issue
9
Pages
2875–2875
Publication date
4 May 2026
Language
EN